Mold-Tek Packaging Q1 FY27 Results: Net Sales Up 24.90% to ₹300.45 Cr, PAT Rises 14.15%
Mold-Tek Packaging reported Q1 FY27 results with Net Sales up 24.90% to ₹300.45 Cr and Net Profit (PAT) up 14.15% to ₹25.57 Cr. EBITDA grew 19.10% to ₹56.43 Cr, and Sales Volume increased by 6.25%. The company achieved a historical high EBITDA per kg of ₹46.68. Expansion plans include entry into Ophthalmic-Packs and medical devices.
Significant year-on-year growth in revenue and profit, coupled with strategic expansion plans into new high-margin segments, indicates a material positive impact on the company's financial performance and future prospects.
The company reported strong year-on-year growth in key financial metrics like Net Sales, Net Profit, and EBITDA, along with a historical high in EBITDA per kg. Expansion plans and positive outlook for key segments also contribute to a positive sentiment.
Mold-Tek Packaging Limited announced its unaudited financial results for the first quarter ended June 30, 2026. The company reported a significant increase in Net Sales by 24.90% to ₹300.45 crores, compared to ₹240.56 crores in the corresponding quarter of the previous year (Q1 FY26).
Net Profit (PAT) also saw a substantial growth of 14.15%, reaching ₹25.57 crores from ₹22.40 crores in Q1 FY26. EBITDA for the quarter rose by 19.10% to ₹56.43 crores, up from ₹47.38 crores in the same period last year. Sales Volume increased by 6.25% to 12,089 MT, compared to 11,378 MT in Q1 FY26. Profit Before Tax (PBT) grew by 13.86% to ₹34.17 crores.
The company highlighted strong demand across various business segments, particularly in Pharma Packs (38.75% growth) and Food & FMCG Packs (26.20% growth). The Paints segment also registered a healthy 10.82% growth. However, Lube Packs experienced a dip due to supply issues related to the Iran war.
Chairman and Managing Director, Mr. J. Lakshmana Rao, stated that the performance reflects the company's focus on operational excellence and strategic consolidation of units in Hyderabad, which has led to improved profitability. The EBITDA per kg reached a historical high of ₹46.68. The company is also planning to enter Ophthalmic-Packs and other medical devices, and is examining entry into Electronics and Semi-conductor packaging.
Further capacity enhancements were commissioned in Q1 for the Pharma Packaging segment and eight additional injection moulding machines were added for the Food & FMCG segment in Sultanpur, Hyderabad. The Food and FMCG packs production at Panipat has doubled, with a focus on growth in the Northern India market. The company has also focused on optimizing label transportation and logistics, leading to reduced costs. The outlook for the Paints segment remains encouraging, with anticipated industry volume growth of 8%-10%.
What to do with a filing like this
Mold-Tek Packaging Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Mold-Tek Packaging Limited. Read the original for the full detail.